Commentary on: Kubicki et al. Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: subanalysis of the randomized phase 3 ATLAS trial. Br J Haematol 2023;203:792–802.
Gozzetti, A., Bernareggi, I., Sammartano, V. (2023). Finding the balance between immunoparesis recovery and multiple myeloma responses after autologous stem cell transplantation in the era of maintenance therapy and novel drugs. BRITISH JOURNAL OF HAEMATOLOGY, 203(5), 706-707 [10.1111/bjh.19132].
Finding the balance between immunoparesis recovery and multiple myeloma responses after autologous stem cell transplantation in the era of maintenance therapy and novel drugs
Gozzetti, Alessandro;Bernareggi, Irene;Sammartano, Vincenzo
2023-01-01
Abstract
Commentary on: Kubicki et al. Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: subanalysis of the randomized phase 3 ATLAS trial. Br J Haematol 2023;203:792–802.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Br J Haematol - 2023 - Gozzetti - Finding the balance between immunoparesis recovery and multiple myeloma responses after.pdf
accesso aperto
Tipologia:
PDF editoriale
Licenza:
Creative commons
Dimensione
142.7 kB
Formato
Adobe PDF
|
142.7 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/1248355
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo